Germ-line mutations of EGFR gene such as T790M or V843I can begin to explain familial aggregation of lung cancer patients; its presence is important in developing resistance to EGFR-TKIs [10, 11, 19–22]. This evidence concerns the gene EGFR and lung cancer.